International Journal of Infection

Published by: Kowsar

Evaluation and Management of Community and Hospital-Acquired Pneumonia for the Primary Care Providers

Suresh J. Antony 1 , * and Catherine Ho 1
Authors Information
1 Texas Tech University Health Sciences Center, Paul Foster School of Medicine, El Paso, Texas, USA
Article information
  • International Journal of Infection: April 01, 2016, 3 (2); e36409
  • Published Online: March 15, 2016
  • Article Type: Review Article
  • Received: January 17, 2016
  • Revised: January 27, 2016
  • Accepted: January 27, 2016
  • DOI: 10.17795/iji-36409

To Cite: Antony S J, Ho C. Evaluation and Management of Community and Hospital-Acquired Pneumonia for the Primary Care Providers, Int J Infect. 2016 ; 3(2):e36409. doi: 10.17795/iji-36409.

Abstract
Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Footnote
References
  • 1. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015; 373(5): 415-27[DOI][PubMed]
  • 2. American Thoracic Society , Infectious Diseases Society of America . Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171(4): 388-416[DOI][PubMed]
  • 3. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001; 163(7): 1730-54[DOI][PubMed]
  • 4. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007; 44 Suppl 2-72[DOI][PubMed]
  • 5. Blasi F. Atypical pathogens and respiratory tract infections. Eur Respir J. 2004; 24(1): 171-81[PubMed]
  • 6. Mills GD, Oehley MR, Arrol B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ. 2005; 330(7489): 456[DOI][PubMed]
  • 7. Aujesky D, Auble TE, Yealy DM, Stone RA, Obrosky DS, Meehan TP, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med. 2005; 118(4): 384-92[DOI][PubMed]
  • 8. Yu VL, Chiou CC, Feldman C, Ortqvist A, Rello J, Morris AJ, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis. 2003; 37(2): 230-7[DOI][PubMed]
  • 9. Dartois N, Cooper CA, Castaing N, Gandjini H, Sarkozy D. Tigecycline versus levofloxacin in hospitalized patients with community-acquired pneumonia: an analysis of risk factors. Open Respir Med J. 2013; 7: 13-20[DOI][PubMed]
  • 10. Lowes R. Tigecycline Mortality Risk: FDA Adds Boxed Warning. 2013;
  • 11. Moran GJ, Rothman RE, Volturo GA. Emergency management of community-acquired bacterial pneumonia: what is new since the 2007 Infectious Diseases Society of America/American Thoracic Society guidelines. Am J Emerg Med. 2013; 31(3): 602-12[DOI][PubMed]
  • 12. Rubinstein E, Lalani T, Corey GR, Kanafani ZA, Nannini EC, Rocha MG, et al. Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens. Clin Infect Dis. 2011; 52(1): 31-40[DOI][PubMed]
  • 13. Cometta A, Baumgartner JD, Lew D, Zimmerli W, Pittet D, Chopart P, et al. Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrob Agents Chemother. 1994; 38(6): 1309-13[PubMed]
  • 14. Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003; 290(19): 2588-98[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments